Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Diffuse Large B-cell Lymphoma (DLBCL)	58
Overall Study	STARTED	Non-Hodgkin Lymphoma (NHL) Excluding DLBCL	27
Overall Study	STARTED	Multiple Myeloma (MM)	81
Overall Study	STARTED	Acute Myeloid Leukemia (AML)	95
Overall Study	STARTED	Other Hematological Malignancies (ALL, CML and CLL)	24
Overall Study	COMPLETED	Diffuse Large B-cell Lymphoma (DLBCL)	0
Overall Study	COMPLETED	Non-Hodgkin Lymphoma (NHL) Excluding DLBCL	0
Overall Study	COMPLETED	Multiple Myeloma (MM)	0
Overall Study	COMPLETED	Acute Myeloid Leukemia (AML)	0
Overall Study	COMPLETED	Other Hematological Malignancies (ALL, CML and CLL)	0
Overall Study	NOT COMPLETED	Diffuse Large B-cell Lymphoma (DLBCL)	58
Overall Study	NOT COMPLETED	Non-Hodgkin Lymphoma (NHL) Excluding DLBCL	27
Overall Study	NOT COMPLETED	Multiple Myeloma (MM)	81
Overall Study	NOT COMPLETED	Acute Myeloid Leukemia (AML)	95
Overall Study	NOT COMPLETED	Other Hematological Malignancies (ALL, CML and CLL)	24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01607892/flow